Members of the Exchange are hereby informed that the trading in equity shares of Parabolic Drugs Limited (ISIN: INE618H01016) shall be suspended w.e.f January 28, 2021 on account of Record date submitted for the purpose of Delisting pursuant to Resolution Plan approved by NCLT